Characterization of AreABC, an RND-Type Efflux System Involved in Antimicrobial Resistance of Aliarcobacter butzleri.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 08 2021
Historique:
pubmed: 22 6 2021
medline: 25 8 2021
entrez: 21 6 2021
Statut: ppublish

Résumé

Aliarcobacter butzleri is an emergent enteropathogen for which resistance to several classes of antimicrobial agents has been described, although the underlying mechanisms have been poorly addressed. We aimed to evaluate the contribution of the resistance-nodulation-division-type (RND) efflux system, AreABC, to drug resistance in A. butzleri. A. butzleri strains were first tested against several antimicrobials with and without an efflux pump inhibitor. Then, erythromycin-resistant strains were screened for the presence of a premature stop codon in a putative transcriptional regulator of the AreABC system,

Identifiants

pubmed: 34152822
doi: 10.1128/AAC.00729-21
pmc: PMC8370231
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0072921

Références

Int J Food Microbiol. 2017 Dec 18;263:32-37
pubmed: 29028568
Clin Microbiol Rev. 2006 Apr;19(2):382-402
pubmed: 16614254
Foodborne Pathog Dis. 2017 Apr;14(4):238-243
pubmed: 28121468
Front Microbiol. 2018 Sep 04;9:2077
pubmed: 30233547
Antimicrob Agents Chemother. 2002 Jul;46(7):2124-31
pubmed: 12069964
FEMS Immunol Med Microbiol. 2007 Apr;49(3):337-45
pubmed: 17378897
J Antimicrob Chemother. 2005 Sep;56(3):491-7
pubmed: 16055509
Front Microbiol. 2017 Apr 24;8:682
pubmed: 28484436
J Antimicrob Chemother. 2011 Jan;66(1):79-85
pubmed: 21081547
J Antimicrob Chemother. 2016 May;71(5):1241-4
pubmed: 26851610
Emerg Infect Dis. 2014 Oct;20(10):1731-4
pubmed: 25271569
Diagn Microbiol Infect Dis. 2014 Mar;78(3):220-5
pubmed: 24361090
Emerg Infect Dis. 2004 Oct;10(10):1863-7
pubmed: 15504280
J Antimicrob Chemother. 2005 Nov;56(5):948-50
pubmed: 16157618
Crit Rev Microbiol. 2016 May;42(3):364-83
pubmed: 25806423
Syst Appl Microbiol. 2020 Jul;43(4):126091
pubmed: 32690190
J Appl Microbiol. 2017 Oct;123(4):1019-1026
pubmed: 28712149
Infect Genet Evol. 2020 Jun;80:104213
pubmed: 32006709
Front Microbiol. 2019 Apr 16;10:670
pubmed: 31057492
J Clin Microbiol. 1992 Sep;30(9):2335-7
pubmed: 1400998
J Antimicrob Chemother. 2006 Jan;57(1):52-60
pubmed: 16303882
Int J Antimicrob Agents. 2004 May;23(5):468-72
pubmed: 15120725
Microbiol Mol Biol Rev. 2005 Jun;69(2):326-56
pubmed: 15944459
J Med Microbiol. 2012 Jun;61(Pt 6):800-808
pubmed: 22361460
Appl Environ Microbiol. 2019 Nov 27;85(24):
pubmed: 31585991
Int J Antimicrob Agents. 2007 Apr;29(4):451-5
pubmed: 17303391
J Clin Microbiol. 2016 Apr;54(4):1082-8
pubmed: 26865686
Foodborne Pathog Dis. 2013 Mar;10(3):250-5
pubmed: 23379282
Antimicrob Agents Chemother. 2013 Mar;57(3):1369-78
pubmed: 23274667
PLoS One. 2015 Jul 01;10(7):e0131534
pubmed: 26132196
Food Microbiol. 2020 Aug;89:103416
pubmed: 32138986
Curr Opin Struct Biol. 2015 Aug;33:76-91
pubmed: 26282926
Microb Drug Resist. 2018 Sep;24(7):915-922
pubmed: 29336679
Helicobacter. 2017 Aug;22(4):
pubmed: 28436598
Clin Microbiol Rev. 2011 Jan;24(1):174-92
pubmed: 21233511
Diagn Microbiol Infect Dis. 2013 Apr;75(4):434-6
pubmed: 23375869
J Glob Antimicrob Resist. 2017 Jun;9:74-77
pubmed: 28400212

Auteurs

Susana Ferreira (S)

CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.

Ana L Silva (AL)

CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.

Joana Tomás (J)

CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.

Cristiana Mateus (C)

CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.

Fernanda Domingues (F)

CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.

Mónica Oleastro (M)

National Institute of Health Ricardo Jorge, Department of Infectious Diseases, National Reference Laboratory for Gastrointestinal Infections, Lisbon, Portugal.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH